PRL, prolactin, 5617

N. diseases: 506; N. variants: 3
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0344452
Disease: Microprolactinoma
Microprolactinoma
0.340 Biomarker disease BEFREE Two women with microprolactinoma diagnosed in perimenopausal period had not been offered DA; PRL decreased (but not normalized) during observation of 1 and 8 years. 29894000 2018
CUI: C0344452
Disease: Microprolactinoma
Microprolactinoma
0.340 Biomarker disease BEFREE 70% and 40% chose to withdraw treatment after 2-3 years of prolactin normalization in microprolactinomas and macroprolactinomas. 30352394 2018
CUI: C0344452
Disease: Microprolactinoma
Microprolactinoma
0.340 Biomarker disease BEFREE 46 and 75 % of respondents favored treatment withdrawal 2-3 years after prolactin normalization in patients with macroprolactinomas and microprolactinomas, respectively whereas 10 % of respondents withdraw treatment after menopause in either case. 27783196 2017
CUI: C0344452
Disease: Microprolactinoma
Microprolactinoma
0.340 Biomarker disease BEFREE It is asserted that the major cause of male homosexuality is due to failure of masculinisation of the male brain due to temporary but critical prolactin secretion from microprolactinoma present in their pituitary glands. 27515200 2016
CUI: C0344452
Disease: Microprolactinoma
Microprolactinoma
0.340 Biomarker disease CTD_human [Disappearance of the radiographic image of a macroprolactinoma after treatment with bromocriptine]. 9617019 1998
CUI: C0344452
Disease: Microprolactinoma
Microprolactinoma
0.340 Biomarker disease CTD_human [A case of prolactinoma presenting with CSF rhinorrhea and CSF otorrhea during bromocriptine therapy]. 1407345 1992
CUI: C0344452
Disease: Microprolactinoma
Microprolactinoma
0.340 Biomarker disease CTD_human Ultrastructural localization of prolactin in estrogen-induced prolactinoma of the rat pituitary. Experimental models for the human prolactinomas and the effects of bromocriptine. 3776530 1986
CUI: C0344452
Disease: Microprolactinoma
Microprolactinoma
0.340 Biomarker disease CTD_human Pituitary apoplexy following chlorpromazine stimulation. 718334 1978